Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial
Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSeveral key resources related to genetics and clinical trials have been removed, including links to MedlinePlus and DailyMed, which may impact access to important health information.SummaryDifference4%
- Check21 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added including links to MedlinePlus and DailyMed, as well as detailed data fields for study information.SummaryDifference4%
- Check36 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.SummaryDifference0.2%
- Check65 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check72 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference0.9%
Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.